NDC 0143-9650 Montelukast
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0143 - West Ward Pharmaceutical Corp
- 0143-9650 - Montelukast
Product Characteristics
PINK (C48328 - PINK)
OVAL (C48345)
11 MM
10 MM
AUM103
AUM102
Product Packages
NDC Code 0143-9650-09
Package Description: 90 TABLET, CHEWABLE in 1 BOTTLE
Price per Unit: $0.11636 per EA
NDC Code 0143-9650-10
Package Description: 1000 TABLET, CHEWABLE in 1 BOTTLE
Price per Unit: $0.11636 per EA
NDC Code 0143-9650-30
Package Description: 30 TABLET, CHEWABLE in 1 BOTTLE
Price per Unit: $0.11636 per EA
Product Details
What is NDC 0143-9650?
What are the uses for Montelukast?
Which are Montelukast UNII Codes?
The UNII codes for the active ingredients in this product are:
- MONTELUKAST SODIUM (UNII: U1O3J18SFL)
- MONTELUKAST (UNII: MHM278SD3E) (Active Moiety)
Which are Montelukast Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- HYDROXYPROPYL CELLULOSE (TYPE H) (UNII: RFW2ET671P)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- CARNAUBA WAX (UNII: R12CBM0EIZ)
- MANNITOL (UNII: 3OWL53L36A)
- CHERRY (UNII: BUC5I9595W)
- ASPARTAME (UNII: Z0H242BBR1)
What is the NDC to RxNorm Crosswalk for Montelukast?
- RxCUI: 200224 - montelukast sodium 10 MG Oral Tablet
- RxCUI: 200224 - montelukast 10 MG Oral Tablet
- RxCUI: 200224 - montelukast 10 MG (as montelukast sodium 10.4 MG) Oral Tablet
- RxCUI: 242438 - montelukast sodium 5 MG Chewable Tablet
- RxCUI: 242438 - montelukast 5 MG Chewable Tablet
* Please review the disclaimer below.
Patient Education
Montelukast
Montelukast is used to prevent wheezing, difficulty breathing, chest tightness, and coughing caused by asthma in adults and children 12 months of age and older. Montelukast is also used to prevent bronchospasm (breathing difficulties) during exercise in adults and children 6 years of age and older. Montelukast is also used to treat the symptoms of seasonal (occurs only at certain times of the year), allergic rhinitis (a condition associated with sneezing and stuffy, runny or itchy nose) in adults and children 2 years of age and older, and perennial (occurs all year round) allergic rhinitis in adults and children 6 months of age and older. Montelukast should be used to treat seasonal or perennial allergic rhinitis only in adults and children who cannot be treated with other medications. Montelukast is in a class of medications called leukotriene receptor antagonists (LTRAs). It works by blocking the action of substances in the body that cause the symptoms of asthma and allergic rhinitis.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".